Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Pregnancy rates and outcomes in women with and without MS in the United States.

Houtchens MK, Edwards NC, Schneider G, Stern K, Phillips AL.

Neurology. 2018 Oct 23;91(17):e1559-e1569. doi: 10.1212/WNL.0000000000006384. Epub 2018 Sep 28.

2.

Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.

Houtchens MK, Edwards NC, Phillips AL.

Neurology. 2018 Oct 23;91(17):e1570-e1578. doi: 10.1212/WNL.0000000000006382. Epub 2018 Sep 28.

3.

It is time to conduct phase 3 clinical trials of sex hormones in MS - No.

Houtchens MK, Desai N.

Mult Scler. 2018 Oct;24(11):1415-1417. doi: 10.1177/1352458518771840. Epub 2018 Jul 30. No abstract available.

PMID:
30058448
4.

A case for gender-based approach to multiple sclerosis therapeutics.

Houtchens MK, Bove R.

Front Neuroendocrinol. 2018 Jul;50:123-134. doi: 10.1016/j.yfrne.2018.07.001. Epub 2018 Jul 21. Review.

PMID:
30040969
5.

Reproductive Issues in MS.

Houtchens MK, Kaplan TB.

Semin Neurol. 2017 Dec;37(6):632-642. doi: 10.1055/s-0037-1608925. Epub 2017 Dec 21. Review.

PMID:
29270936
6.

Contraception for women with multiple sclerosis: Guidance for healthcare providers.

Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.

Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24. Review.

7.

Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.

Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R.

Int J Neurosci. 2017 Nov;127(11):971-980. doi: 10.1080/00207454.2017.1283313. Epub 2017 Feb 2.

PMID:
28100092
8.

Contraceptive use among women with multiple sclerosis: a systematic review.

Zapata LB, Oduyebo T, Whiteman MK, Houtchens MK, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21. Review.

9.

An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.

Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, Weiner HL, Ceccarelli A.

Neuroreport. 2014 Oct 1;25(14):1156-61. doi: 10.1097/WNR.0000000000000244.

10.

JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ.

Ann Neurol. 2014 Jun;75(6):925-34. doi: 10.1002/ana.24148. Epub 2014 Jun 10.

11.

Multiple sclerosis and pregnancy: therapeutic considerations.

Houtchens MK, Kolb CM.

J Neurol. 2013 May;260(5):1202-14. doi: 10.1007/s00415-012-6653-9. Epub 2012 Aug 25. Review.

PMID:
22926165
12.

A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.

Klein JP, Arora A, Neema M, Healy BC, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Stankiewicz JM, Cohen AB, Buckle GJ, Houtchens MK, Ceccarelli A, Dell'Oglio E, Guttmann CR, Alsop DC, Hackney DB, Bakshi R.

AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1138-42. doi: 10.3174/ajnr.A2459. Epub 2011 Apr 28.

13.

The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.

Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Ceccarelli A, Klein JP, Stankiewicz JM, Houtchens MK, Buckle GJ, Alsop DC, Guttmann CR, Bakshi R.

J Neuroimaging. 2012 Apr;22(2):122-8. doi: 10.1111/j.1552-6569.2011.00589.x. Epub 2011 Mar 29.

14.

Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R.

J Neuroimaging. 2011 Apr;21(2):e50-6. doi: 10.1111/j.1552-6569.2009.00449.x.

15.

3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.

Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R.

Neuroimage. 2009 Jul 1;46(3):633-41. doi: 10.1016/j.neuroimage.2009.03.001. Epub 2009 Mar 10.

16.

Pregnancy and multiple sclerosis.

Houtchens MK.

Semin Neurol. 2007 Nov;27(5):434-41. Review.

PMID:
17940922
17.

Thalamic atrophy and cognition in multiple sclerosis.

Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CR, Bakshi R.

Neurology. 2007 Sep 18;69(12):1213-23.

PMID:
17875909
18.

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SJ, Guttmann CR, Weiner HL.

Mult Scler. 2007 Sep;13(8):1004-10. Epub 2007 Jul 10.

PMID:
17623735
19.

Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis.

Rose JW, Welsh CT, Hill KE, Houtchens MK, Fujinami RS, Townsend JJ.

J Neuroimmunol. 1999 Jun 1;97(1-2):110-8.

PMID:
10408964
20.

Open label gabapentin treatment for pain in multiple sclerosis.

Houtchens MK, Richert JR, Sami A, Rose JW.

Mult Scler. 1997 Aug;3(4):250-3.

PMID:
9372509

Supplemental Content

Loading ...
Support Center